Clinical Trials on 5-Fluorouracil Toxicity in Hungary

Total 4 results

National Institute of Oncology, Hungary

Active, not recruiting

Accelerated Partial Breast Irradiation With 3D-CRT and IMRT (APERT)

Breast Cancer | Radiation Toxicity | Side Effects

Hungary
State Health Center, Hungary

Completed

Is Verapamil In TransRadial Interventions OmittabLe? (VITRIOL)

Coronary Disease | Verapamil Toxicity

Hungary
G1 Therapeutics, Inc.

Terminated

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): (PRESERVE1)

Colorectal Cancer Metastatic | Chemotherapeutic Toxicity | Myelosuppression-Adult

China, Spain, United States, Hungary, United Kingdom, Poland, Ukraine, Italy
AstraZeneca

Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

Cervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5

Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia

3

Subscribe